IL10 and cerebral malaria: Injection of recombinant IL-10 protected susceptible mice from experimental cerebral malaria induced by Plasmodium berghei infection (7), and ablation of IL-10 resulted in higher plasma levels of pro-inflammatory cytokines and increased mortality of Plasmodium chabaudi-infected mice (8).